Pirkko Korsoff

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A nationwide study on parathyroid carcinoma

Eeva Ryhänen, Helena Leijon, Saara Metso et al. · Acta Oncologica · 2017 · 127 citations · Full text

Medicine, Endocrinology, Oncology +14

The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors

Saila Kauhanen, Marko Seppänen, Jari Ovaska et al. · Endocrine Related Cancer · 2008 · 97 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Complementary Roles of ¹⁸F-DOPA PET/CT and ¹⁸F-FDG PET/CT in Medullary Thyroid Cancer

Saila Kauhanen, Camilla Schalin‐Jäntti, Marko Seppänen et al. · Journal of Nuclear Medicine · 2011 · 85 citations · Full text

Medicine, Nuclear Medicine, Radiology +17